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Prealbumin is a very rapid turnover protein produced by hepatocytes. 
We studied the association of serum prealbumin concentration with 
prognosis in 55 patients with liver cirrhosis. These included 28 men 
and 27 women, aged 46 to 70 years old (mean ± SD: 55.9 ± 10.8 years 
old). 
The clinical stages of these 55 patients at base line were classified 
according to the Pugh's scoring system; 39 were in stage A, 12 in stage 
B and 4 in stage C. During follow-up, 3 of 12 stage B patients as well as 
all of the four stage C patients died from hepatic failure, whereas none 
of 39 stage A patients died. When the prognostic factors were 
analyzed in 16 patients with stage B or C, the base line serum 
prealbumin concentration was significantly lower in 7 died patients 
than in 9 alive patients (P < 0.05); in contrast, the serum bilirubin 
level, the serum albumin concentration or prothrombin time at base 
line were not different between the two groups (P > 0.05, P > 0.1 and P 
> 0.4, respectively). 
These results suggest that the serum prealbumin concentration can be 
used clinically as a prognostic marker in patients with liver cirrhosis.
Introduction 
With the recent advances in the treatment modalities, sur-
vival of patients with liver cirrhosis is much improved,'' 
although patients with advanced cirrhosis have as yet poor 
prognosis.'' Child-Turcotte's classification 6' and Pugh's 
classification'' are available for setting patients with liver 
cirrhosis in their clinical stages; however, their scoring 
systems indicate the reserved function of the liver only at 
the time of study and cannot be used in order to predict the 
prognosis of each patient. 
 Prealbumin is a very rapid turnover protein produced by 
hepatocytes, and its plasma half life is approximately 2 
days. Since the serum prealbumin concentrations exclu-
sively depend on liver function with the exception of long-
term starvation and hyperthyroidism,'' it is possible that the 
serum prealbumin concentrations are closely associated 
with the reserved function of the liver in patients with liver 
cirrhosis. In this study, the prognosis of patients with liver 
cirrhosis was prospectively analyzed by the serum preal-
bumin concentration.
Methods 
During 1988-90, 75 cirrhotic patients without hepato-
cellular carcinoma were admitted to the National Saga 
hospital. Among them, patients with Wilson's disease, 
primary biliary cirrhosis and autoimmune hepatitis as well 
as those with alcohol abuse were excluded from the study. 
Also the patients who received frozen plasmas within one 
month before the study were excluded. Thus, 55 patients 
with liver cirrhosis were entered into the study; 28 were 
men and 27 were women, aged 46 to 70 years old. The 
diagnosis of liver cirrhosis was made by laparoscopy, liver 
biopsy or both in all the 55 patients. The clinical stages of 
the 55 patients at base line were classified according to the 
Pugh's scoring system; 39 were in stage A, 12 in stage B 
and 4 in stage C. 
 The patients were followed without specific treatments 
such as administration of interferons and corticosteroids. 
Serum prealbumin concentrations were measured by 
immuno-precipitation method using anti-prealbumin-coated 
latex beads. The values in 120 control subjects aged 22 to 
48 years old (median: 36 years old) ranged from 12 to 
38mg/dl. Serum prealbumin concentrations were also de-
termined in 50 patients with chronic hepatitis who were 
followed in National Saga hospital during the same period. 
Hepatitis B surface antigen (HBsAg) and anti-hepatitis C 
virus antibody (anti-HCV) were assayed using commer-
cially available kits (Dinabot Co., Ltd., Japan and Ortho 
Co., Ltd., U. S. A., respectively). 
 Statistical analyses were carried out using Student's t test 
and the chi-square test. P values less than 0.05 were 
considered statistically significant.
Results 
Serum prealbumin concentrations in patients with liver 
cirrhosis 
The serum prealbumin concentration in patients with liver 
cirrhosis was compared with that in patients with chronic 
hepatitis (Table 1). Sex ratio and the positivity rate for
Table 1. Variates in patients with chronic hepatitis and in 
       patients with liver cirrhosis
                        chronic hepatitis liver cirrhosis 
                       (n = 50) (n = 55)
male/female 30/20 28/27 
age (y. o.) 45.3 ± 13.6 55.9 ± 10.8' 
HBsAg (+) 6 6 
anti-HCV (+) 44 48 
Both (-) 0 1 
Serum prealbumin concentra- 26.8 ± 6.0 16.4 ± 5.1b tion (mg/dl) 
ep<0 .05,bp<0.01
significantly lower than those in 9 alive patients (mean ± 
SD: 8.4 ± 1.1 vs 12.0 ± 4.Omg/dl, P < 0.05) (Fig. 1); in 
contrast, neither the serum bilirubin levels, the serum 
albumin concentrations nor prothrombin time at base line 
were different between the two groups (Table 4).
HBsAg or anti-HCV were similar bitween the two groups. 
The mean age in patients with liver cirrhosis was older than 
that in patients with chronic hepatitis (P < 0.01). The serum 
prealbumin concentrations in patients with chronic hepatitis 
and in patients with liver cirrhosis were 26.8 ± 6.0 and 
16.4 ± 5.lmg/dl (mean ± SD), respectively. The differ-
ence was statistically significant (P < 0.01). When the 
association of the serum prealbumin concentrations with 
clinical stages of liver cirrhosis was studied, the serum 
prealbumin concentration was significantly higher in stage 
A patients than in stage B patients and followed by stage C 
patients (Table 2). 
Relationship between patients' prognosis and the base line 
serum prealbumin concentration 
During follow-up, 7 of 55 patients with liver cirrhosis died 
from hepatic failure; 3 were in stage B and 4 were in stage 
C at base line, whereas all the patients with stage A at base 
line were alive (Table 3). Thus, the base line values were 
analyzed in 16 patients with stage B or C. The baseline 
serum prealbumin concentrations in 7 dead patients were
Fig. 1. Comparison of the base line serum prealbumin concen-
trations between patients died and patients survived.
Table 2. The base line values in patients with liver cirrhosis
                                                           liver cirrhosis 
                               Stage A (n = 39) Stage B (n = 12) Stage C (n = 4) 
 total bilirubin (mg/dl) 0.74 ± 0.23'. b 1.75 ± 0.75 6.11 ± 3.30 
 albumin (g/dl) 4.5 ± 0.8 4.3 ± 1.7 3.6 ± 1.2 
 prothrombin time (sec.) 15.6 ± 2.0` 18.6 ± 2.3 19.5 ± 1.0 
 prealbumin (mg/dl) 18.8 ± 5.9` 11.5 ± 3.7° 8.3 ± 1.0 
Clinical stages of liver cirrhosis are classified according to the Pugh's scoring system. .
p < 0.05 vs stage B, by < 0.01 vs stage C, `p < 0.01 vs stage B and C, °p < 0.05 vs stage C
Table 3. The prognosis of patients with liver cirrhosis by the 
       Pugh's clinical stage
Table 4. Comparison of the base line values between patients 
       died and patients alive
                   Pugh's clinical stage at base line 
               Stage A Stage B Stage C 
              (n = 39) (n = 12) (n = 4)
 Patients died 0 3(25) 4(100) 
 Patients alive 39(100) 9(25) 0
                   patients died patients alive p-values                   (
n=7) (n=9) 
total bilirubin (mg/dl) 4.46 ± 3.15 1.60 ± 0.62 p > 0.05 
albumin (g/dl) 3.5 ± 0.5 3.8 ± 0.4 p > 0.1 
prothrombin time (sec.) 18.5 ± 1.9 18.3 ± 1.6 p > 0.8
Discussion 
This study showed that the serum prealbumin concentration 
in patients with liver cirrhosis was significantly lower than 
that in patients with chronic hepatitis, and closely asso-
ciated with clinical stages classified by the Pugh's scoring 
system. When the prognosis of patients with liver cirrhosis 
was prospectively analyzed by the base line serum preal-
bumin concentrations, the values were significantly lower 
in patients who died from hepatic failure than in alive 
patients. The Pugh's score somewhat indicated the prog-
nosis of patients because all of stage A patients were alive 
during follow-up; however, neither the serum bilirubin 
level, the serum albumin concentration nor prothrombin 
time at base line were associated with survival of stage B 
and C patients. 
  In the cirrhotic liver, the histological progression is 
accompanied with the reduction of the effective hepatic 
blood flow, resulting in the further decrease in the reserved 
function of the liver." In fact, the galactose clearance rate 
which exlusively depends on the effective hepatic perfu-
sion is clearly reduced in patients with liver cirrhosis."' 
Since the serum prealbumin concentration was found to 
correlate closely with the galactose clearance rate,"' the 
decreased serum prealbumin concentration in patients with 
liver cirrhosis seems to be mainly due to the reduction of 
the effective hepatic blood flow. 
  In conclusion, this study shows that the serum preal-
bumin concentration can be used as a prognostic marker in 
patients with liver cirrhosis.
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